Tag:
CRT-D
Latest Headlines
Latest Headlines
Medtronic Q4 earnings jumped just 3%
If not for the continued sluggish performance of Medtronic's ($MDT) spine division and flat ICD and pacer sales, the company fiscal 2012 fourth quarter earnings growth ended up being pretty solid, if unspectacular.
Biotronik wins FDA approval for next-gen ICD and CRT-D
The competition to gain market share with next-generation ICD and CRT-Ds just got tougher. German device giant Biotronik won FDA regulatory approval for its new Lumax 740 implantable cardioverter defibrillators and cardiac resynchronization therapy devices.
Abbott, St. Jude ink cardiac co-promotion deal
Abbott ($ABT) and St. Jude Medial ($STJ) are expanding an arrangement that enables them to jointly promote each other's stents, defibrillators and other cardiac-related devices, imaging and diagnostic tech.
St. Jude yanks 2 CRT leads from market
St. Jude Medical ($STJ) is confronting yet another problem with faulty leads. The company stopped selling its QuickSite and QuickFlex left ventricular leads for cardiac resynchronization therapy devices after confirming at least 39 cases of worn insulation.
Boston Sci wins FDA nod for heart failure devices
The FDA has given its blessing to Boston Scientific's ( $BSX ) INCEPTA, ENERGEN and PUNCTUA CRT-Ds and ICDs to treat heart failure and sudden cardiac death. In a release, the company touts the devices'
